You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

22-208

Showing 1 - 25 of 3,972
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

DLBCL, Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma Trial in Seattle (procedure, drug, biological)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • +2 more
  • Biopsy
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 12, 2022

COVID-19 Trial in Worldwide (LY3819253, Placebo, Remdesivir)

Completed
  • COVID-19
  • LY3819253
  • +2 more
  • Tucson, Arizona
  • +56 more
Mar 22, 2023

Brain Cancer, Glioblastoma, Metastatic Cancer Trial in New York (Trastuzumab deruxtecan)

Recruiting
  • Brain Cancer
  • +4 more
  • Trastuzumab deruxtecan
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Sep 22, 2023

Random Biopsies Versus Wide-Area Transepithelial Brush-Sampling

Recruiting
  • Barrett Esophagus
  • +2 more
  • WATS3D
  • Amsterdam, Noord Holland, Netherlands
    Amsterdam University Medical Centre, loc. VUmc
Dec 6, 2022

Influenza, Human, Infections, Respiratory Tract Infections Trial in United States (aH5N8c on Day 1, aH5N6c on Day 1, aH5N8c on

Not yet recruiting
  • Influenza, Human
  • +4 more
  • aH5N8c on Day 1
  • +4 more
  • Cullman, Alabama
  • +8 more
May 15, 2023

COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)

Completed
  • COVID-19
  • BRII-196
  • +3 more
  • Tucson, Arizona
  • +106 more
Mar 24, 2023

COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)

Completed
  • COVID-19
  • VIR-7831
  • +2 more
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

COVID-19 Trial in Worldwide (MP0420, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • AZD7442
  • +2 more
  • Tucson, Arizona
  • +123 more
Mar 24, 2023

Lateral Canthal Lines, Crow's Feet Trial in United States (botulinum toxin, Type A, Vehicle)

Completed
Has Results
  • Lateral Canthal Lines
  • Crow's Feet
  • botulinum toxin, Type A
  • Vehicle
  • Miami, Florida
  • +4 more
Jul 27, 2022

Mental Health Disorders, Substance Use Disorders Trial (Full MISSION, Linkage Only Delivered by a Peer Specialist)

Not yet recruiting
  • Mental Health Disorders
  • Substance Use Disorders
  • Full MISSION
  • Linkage Only Delivered by a Peer Specialist
  • (no location specified)
Feb 3, 2023

Myocardial Infarction, Acute Trial in Cairo (No intervention)

Completed
  • Myocardial Infarction, Acute
  • No intervention
  • Cairo, Egypt
    Biochemistry Department, Faculty of Pharmacy and Biotechnology,
Jan 18, 2023

Chronic Graft-versus-host-disease Trial in United States (Belumosudil 200 mg QD, Belumosudil 200 mg BID, Belumosudil 400 mg QD)

Active, not recruiting
  • Chronic Graft-versus-host-disease
  • Belumosudil 200 mg QD
  • +2 more
  • Duarte, California
  • +7 more
Aug 5, 2022

Acute Lymphoblastic Leukemia Trial in Memphis (Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine
  • Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jul 26, 2022

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Worldwide (tisotumab vedotin)

Completed
  • Ovarian Cancer
  • +2 more
  • tisotumab vedotin
  • San Jose, California
  • +36 more
Jul 8, 2022

Typhoid, Cholera, Measles Trial (Oral Cholera Vaccine (OCV), Typhoid Conjugate Vaccine (TCV), Measles and Rubella (MR))

Not yet recruiting
  • Typhoid
  • +3 more
  • Oral Cholera Vaccine (OCV)
  • +2 more
  • (no location specified)
Mar 5, 2023

Prostate Cancer Trial in Worldwide (Apalutamide, Placebo, Androgen Deprivation Therapy (ADT))

Active, not recruiting
Has Results
  • Prostate Cancer
  • Homewood, Alabama
  • +228 more
Aug 2, 2022

Lupus Erythematosus, Systemic Trial in Worldwide (Placebo, Ustekinumab (approximately 6 mg/kg), Ustekinumab 90 mg)

Terminated
Has Results
  • Lupus Erythematosus, Systemic
  • Placebo
  • +2 more
  • Anniston, Alabama
  • +203 more
Jan 31, 2023

Alzheimers Disease, Dementia, Alzheimers Disease, Familial Trial in Worldwide (Gantenerumab, Solanezumab, Matching Placebo

Completed
Has Results
  • Alzheimers Disease
  • +2 more
  • Birmingham, Alabama
  • +24 more
Aug 25, 2022

Periodontitis, Diabetes, Type 2 Trial in Istanbul (Non-Surgical Periodontal Treatment)

Completed
  • Periodontitis
  • Diabetes Mellitus, Type 2
  • Non-Surgical Periodontal Treatment
  • Istanbul, Turkey
    Marmara University
Nov 11, 2023

Renal Insufficiency, Chronic Trial in Richmond (Whole-body Passive Heat Therapy (HT), Thermoneutral Control (CON))

Recruiting
  • Renal Insufficiency, Chronic
  • Whole-body Passive Heat Therapy (HT)
  • Thermoneutral Control (CON)
  • Richmond, Virginia
    Virginia Commonwealth University
Jun 20, 2023

Multiple Myeloma Trial in Canton (Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Canton, Ohio
    Gabrail Cancer & Research Center
Oct 11, 2023

Ankle Sprains, Chronic Pain Trial in Lahore (Group A - Closed Chain Exercise, Group B - Neuromuscular Training Exercise)

Completed
  • Ankle Sprains
  • Chronic Pain
  • Group A - Closed Chain Exercise
  • Group B - Neuromuscular Training Exercise
  • Lahore, Punjab, Pakistan
    Pakistan Sports Board
Jul 31, 2023

Smoking Cessation Trial in Tampa (Very Low Nicotine Content (VLNC) Cigarettes, One on One Counseling)

Completed
Has Results
  • Smoking Cessation
  • Very Low Nicotine Content (VLNC) Cigarettes
  • One on One Counseling
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 10, 2022

Intensive Care Unit Syndrome Trial in Amasya (Abdominal massage)

Recruiting
  • Intensive Care Unit Syndrome
  • Abdominal massage
  • Amasya, Turkey
    Amasya U
Oct 3, 2023